Savant Capital LLC Has $2.09 Million Stock Holdings in MetLife, Inc. (NYSE:MET)

Savant Capital LLC boosted its position in shares of MetLife, Inc. (NYSE:METFree Report) by 4.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 25,488 shares of the financial services provider’s stock after purchasing an additional 1,152 shares during the quarter. Savant Capital LLC’s holdings in MetLife were worth $2,087,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in MET. Swedbank AB raised its position in shares of MetLife by 76.0% during the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after acquiring an additional 1,496,645 shares during the last quarter. Zurich Insurance Group Ltd FI acquired a new stake in shares of MetLife during the third quarter worth $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its position in shares of MetLife by 79.1% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock valued at $142,378,000 after acquiring an additional 762,291 shares during the period. Jacobs Levy Equity Management Inc. boosted its stake in MetLife by 256.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock worth $78,209,000 after acquiring an additional 682,333 shares during the last quarter. Finally, Nordea Investment Management AB grew its holdings in MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after purchasing an additional 608,224 shares during the period. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Price Performance

NYSE:MET opened at $82.77 on Thursday. The stock has a market capitalization of $57.31 billion, a PE ratio of 13.86, a P/E/G ratio of 0.64 and a beta of 1.07. The firm has a fifty day simple moving average of $83.59 and a 200 day simple moving average of $80.98. MetLife, Inc. has a 1-year low of $67.04 and a 1-year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, research analysts expect that MetLife, Inc. will post 9.63 EPS for the current fiscal year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.63%. MetLife’s dividend payout ratio (DPR) is 36.52%.

Wall Street Analysts Forecast Growth

MET has been the subject of a number of recent analyst reports. BMO Capital Markets initiated coverage on shares of MetLife in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective for the company. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Wells Fargo & Company cut their price target on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 14th. Keefe, Bruyette & Woods lowered their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday. Finally, Barclays cut their price target on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $92.17.

Check Out Our Latest Research Report on MET

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.